BackGinkgo Bioworks Holdings Overview

Ginkgo Bioworks Holdings Current Cash

Track Ginkgo Bioworks Holdings's current cash ($85M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$84.53M
↓ 58.47% YoYΔ $-119.03M vs prior year quarter

Peer trimmed avg / median

Loading

Ginkgo Bioworks Holdings Current Cash History

Loading

Ginkgo Bioworks Holdings vs. peers: Current Cash Comparison

Loading

Ginkgo Bioworks Holdings Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Ginkgo Bioworks Holdings (DNA) FAQ

As of the most recent data (June 2026), DNA shows a current cash of $85M. That compares with $200M in the prior-year period — down 58.5% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, DNA's current cash is now $85M (was $200M) — a 58.5% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Ginkgo Bioworks Holdings is outperforming or lagging.

Tracking DNA's current cash over time shows whether Ginkgo Bioworks Holdings is scaling, shrinking, or reshaping that part of the business. The current reading is $85M That compares with $200M in the prior-year period — down 58.5% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current cash page, Stockcircle has Ginkgo Bioworks Holdings's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current cash (currently $85M) with ownership activity and broader fundamentals.

Ginkgo Bioworks Holdings's current cash is $85M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.